Optifen Junior, Suspension zum Einnehmen
7680669030025
CH-66903
suspension
Associated product:
OPTIFEN Junior susp 100 mg/5ml fl 200 ml
1 / 3
google
Article details
- Package size
- 200
- Selling units
- 200
- Measure
- ml
- Galenic form
- suspension
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1447.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
9.0 MG | Substance | HBESI |
|
(N/A)
|
1.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.86 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 13.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2019
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 66903
- Drug name
- Optifen Junior, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- M01AE01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 08/11/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.10.1.
- Domain
- Human medicine
Package details
- Description (FR)
- OPTIFEN Junior susp 100 mg/5ml fl 200 ml
- Description (DE)
- OPTIFEN Junior Susp 100 mg/5ml Fl 200 ml
- Market launch
- 08/11/2018
- Narcotic (BTM)
- No
Original drug
Algifor Junior, Suspension
GTIN: 7680560460013
CHF 13.95
Other package sizes (1)
None
100 ML
GTIN: None